Growington Vent (539222)
TurnaroundScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5.3 |
| Market Cap | ₹85.09 Cr |
| P/E Ratio | 15.8 |
| ROCE | 17.26% |
| ROE | 12.54% |
| Dividend Yield | 0% |
| Profit Growth | -46.84% |
| Debt/Equity | — |
| Sales Growth | 71.46% |
| 52-Week Range | ₹0.59 — ₹5.3 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹0.31 |
Strengths
- Strong top-line momentum with 71.46% sales growth
- Latest quarter profitable: ₹1 Cr net profit on ₹25 Cr sales
- ROCE of 17.26% and ROE of 12.54% show reasonable capital efficiency
- Stock at 52-week high, indicating market interest and momentum
Concerns
- Profit growth is sharply negative at -46.84% despite sales growth
- Extremely high P/B of 17.10 versus book value of ₹0.31 leaves little margin of safety
- Piotroski F-Score of 4/9 reflects weak financial health
- No dividend, and missing promoter holding and debt/equity data create transparency risks
AI Analysis
Walking into Growington Vent, I see an ₹85 crore trading and distribution company at ₹5.30, having touched its 52-week high. The stock has moved from ₹0.59 to ₹5.30, which makes investors excited, but I try to stay calm and read the underlying economics. Sales grew 71.46%, yet profit declined by 46.84%. That is not the combination I look for. In the latest quarter, revenue was ₹25 crore and net profit just ₹1 crore—a thin 4% margin. A trading business rarely has pricing power; it lives on volume and execution. There is no moat, and the numbers confirm it. The balance sheet is not my friend either. Book value is ₹0.31, so the stock trades at 17.1 times book. Paying that for a distributor requires exceptional future growth, not falling profits. The P/E of 15.80 looks modest, but if earnings are dropping, today's multiple will be higher tomorrow. Return on equity is 12.54% and ROCE 17.26%, which are decent, but they are not enough to justify this price. The Piotroski F-score of 4 out of 9 signals weak financial health. There is no dividend, so a patient shareholder earns nothing while waiting. The PEG ratio of 0.22 is misleading because it assumes the earnings growth that the company is not currently delivering. I also notice that promoter holding and debt-to-equity are not available. When a company does not disclose key ownership and leverage data, I become more skeptical. In Graham's framework, investing is about margin of safety. At this price, with declining profits, low book value, and poor F-score, there is very little margin of safety. I would keep this on my watchlist, not in my portfolio. Let the business prove it can turn its 71% sales growth into sustainable earnings before I pay a premium.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer